FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

32570211000036100: Substance foundation reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Nov 2009. Module: SNOMED Clinical Terms Australian extension

Descriptions:

Id Description Lang Type Status Case? Module
108642371000036113 Substance foundation reference set (foundation metadata concept) en Fully specified name Active Case insensitive SNOMED Clinical Terms Australian extension
108642381000036110 Substance foundation reference set en Synonym Active Case insensitive SNOMED Clinical Terms Australian extension
4351461000168113 <p>Supports the recording of substances in Australian e-health implementations.</p><p>This reference set can be used:<ul><li>Within implementations where use-case specific reference sets for substances are yet to be developed.</li><li>As the basis for developing further use-case specific reference sets for substances, through a process of constraint.</li><li>As a benchmark against which use-case specific reference sets that have been developed by the SNOMED CT-AU user community can be tested to assure that they are logical constraints of content relating to substances.</li></ul></p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive SNOMED Clinical Terms Australian extension


27331 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance foundation reference set Developed by Australian Digital Health Agency true Inferred relationship Some 926724414
Substance foundation reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1675684939
Substance foundation reference set Is a Foundation reference sets true Inferred relationship Some
Substance foundation reference set Is a Attribute value type false Inferred relationship Some
Substance foundation reference set Is a Simple type reference set true Inferred relationship Some

Members
Carboxylase
Catechol-O-methyltransferase inhibitor
Cellular transport activator
Cellular transport inhibitor
Central alpha-2 adrenergic receptor agonist
Centrally acting acetylcholinesterase inhibitor
Ceramide glucosyltransferase inhibitor
Chelating agent
Chemokine receptor antagonist
Coagulation factor Xa inhibitor
Coagulation factor inhibitor
Complement 5 inhibitor
Substance with complement inhibitor mechanism of action (substance)
Substance with corticotropin releasing hormone antagonist mechanism of action
Substance with cresol structure
Cyclic lipopeptide antibacterial
Substance with cyclopropane structure
Cystic fibrosis transmembrane conductance regulator potentiator
Cytidine deaminase inhibitor
Cytochrome P450 17A1 inhibitor
Cytochrome P450 2C19 inhibitor
Cytochrome P450 2D6 inhibitor
Cytochrome P450 inhibitor
Cytotoxic T-lymphocyte-associated protein 4 inhibitor
Decarboxylase
Dehydrogenase inhibitor
Dehydrogenase
Dihydrofolate reductase inhibitor
Dihydropyridine derivative calcium channel blocker
Dihydroxyphenylalanine decarboxylase inhibitor
Dipeptidyl peptidase IV inhibitor
Direct thrombin inhibitor
Substance with dopamine receptor D2 antagonist mechanism of action
Dopamine receptor agonist
Dopamine receptor antagonist
Dopamine reuptake inhibitor
Effector
Elastase inhibitor
Endothelin receptor antagonist
Enzyme activator
Enzyme inhibitor
Enzyme
Enzyme reactivator
Epidermal growth factor receptor antagonist
Erythropoietin receptor agonist
Estrogen receptor agonist
Estrogen receptor antagonist
Substance with ether structure
Etiopathic disposition
Farnesoid X receptor agonist
Fibroblast growth factor receptor inhibitor
Gamma-aminobutyric acid A receptor agonist
Gamma-aminobutyric acid receptor agonist
GABA receptor antagonist
Gamma-hydroxybutyrate receptor agonist
Ganglion blocking agent
Glucagon-like peptide 1 receptor agonist
Glucagon-like peptide 2 receptor agonist
Substance with glucocorticoid receptor antagonist mechanism of action
Glucosyltransferase
Glutamate receptor antagonist
Glutathione transferase inhibitor
Glycopeptide antibiotic
Platelet glycoprotein-IIb/IIIa receptor antagonist
Substance with glycosidase inhibitor mechanism of action
Substance with glycosyltransferase inhibitor mechanism of action
Gonadotropin
Gonadotropin releasing hormone receptor antagonist
Growth hormone receptor agonist
Growth hormone receptor antagonist
Growth hormone secretagogue receptor agonist
Guanylate cyclase 2C agonist
Halogenated hydrocarbon insecticide
Haemoglobin S polymerization inhibitor
Hexosyltransferase inhibitor
Histamine H1 receptor antagonist
Histamine H2 receptor antagonist
Histamine H3 receptor antagonist
Histamine receptor agonist
Histamine receptor antagonist
Substance with histone deacetylase inhibitor mechanism of action
Hormone antagonist
Human epidermal growth factor receptor 2 inhibitor
Proton pump inhibitor
Hydrolase inhibitor
Hydrolase
Hypothalamic inhibiting factor
Ileal bile acid transporter inhibitor
Imidazole antifungal
Imidazoline receptor agonist
Immune checkpoint inhibitor
Immunomodulator
Insulin antagonist
Integrase strand transfer inhibitor
Inter-alpha-trypsin inhibitor
Interferon gamma inhibitor
Interleukin 1 receptor antagonist
Interleukin 23 receptor antagonist
Interleukin 5 receptor antagonist
Interleukin 6 receptor antagonist
Interleukin receptor antagonist

Start Previous Page 244 of 274 Next End


Reference Sets

Reference set descriptor

Back to Start